Olívia Wu

ORCID: 0000-0002-0570-6016 · 8 papers in corpus
2023
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.14626

ObjectiveTo determine treatment options (myomectomy vs. uterine artery embolization (UAE)) for women wishing to avoid hysterectomy.MethodsA multicenter randomized controlled trial was conducted on 254 women and data were collected on fibroi…

article 2023
·doi:10.1172/jci.insight.171305

Uterine leiomyomas cause heavy menstrual bleeding, anemia, and pregnancy loss in millions of women worldwide. Driver mutations in the transcriptional mediator complex subunit 12 (MED12) gene in uterine myometrial cells initiate 70% of leiom…

rct 2022
Health technology assessment (Winchester, England) ·doi:10.3310/ZDEG6110

BACKGROUND: Uterine fibroids are the most common tumour in women of reproductive age and are associated with heavy menstrual bleeding, abdominal discomfort, subfertility and reduced quality of life. For women wishing to retain their uterus …

article 2021
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2021.100139

OBJECTIVE: To examine the quality of life experienced by women with symptomatic uterine fibroids who had been treated with UAE in comparison to myomectomy. We report the four-year follow-up of the FEMME randomised trial. Two-year follow-up …

article 2016
PloS one ·doi:10.1371/journal.pone.0153037

Chronic pelvic pain (CPP) affects 2.1-24% of women. Frequently, no underlying pathology is identified, and the pain is difficult to manage. Gabapentin is prescribed for CPP despite no robust evidence of efficacy. We performed a pilot trial …

2014
Trials ·doi:10.1186/1745-6215-15-468

BackgroundUterine fibroids are the most common tumour in women of reproductive age. By the time they are 50-years-old around 80% of women will have developed one. Of these, around half will experience symptoms which will impact negatively o…

article 2012
BMJ open ·doi:10.1136/bmjopen-2012-001297

INTRODUCTION: Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescri…

article 2007
·doi:10.1111/j.1471-0528.2007.01525.x

OBJECTIVES: To evaluate the relative cost-effectiveness of uterine artery embolisation (UAE) and hysterectomy in women with symptomatic uterine fibroids from the perspective of the UK NHS. DESIGN: Cost-utility analysis. SETTING: Eighteen UK…